The US Food and Drug Administration on Monday approved the antibody drug Aduhelm (generic name aducanumab) to treat Alzheimer’s disease. Aduhelm is the first new Alzheimer’s drug to earn FDA approval since 2003.
ORIGINAL LINK
“Those who are able to see beyond the shadows and lies of their culture will never be understood, let alone believed, by the masses.” - Plato
Seeking Truth in a World of Propaganda. Links do not necessarily indicate agreement with stories or perspectives.
Wednesday, June 9, 2021
A “disgraceful decision:” Researchers blast FDA for approving Alzheimer’s drug
The US Food and Drug Administration on Monday approved the antibody drug Aduhelm (generic name aducanumab) to treat Alzheimer’s disease. Aduhelm is the first new Alzheimer’s drug to earn FDA approval since 2003.
ORIGINAL LINK